Clet niyikiza biography of barack obama
Home / Political Leaders & Public Figures / Clet niyikiza biography of barack obama
Kenley Hoover
Outside Intellectual Property Counsel
Dr. Founder and former President of I-Trax Medical Solutions (Amex: DMX). Previously, he was a senior executive at the CIA, he held several senior posts at CIA Headquarters with worldwide responsibility and was a Chief of Station three times and had six overseas tours in clandestine operations in his 27-year career.
Brigadier General Dr.
David Young III (Ret)
Young joined the Air Force in 1980. His experience includes all aspects of IP law, including patent prosecution, litigation, opinions, interferences, oppositions, licensing and complex technology driven transactions.
As a thought leader in the pharmaceutical, biotechnology, and life science industries, Dr.
Hoover provides in-depth strategic counseling and support on all matters relating to the development, transfer, and strategic management of patents and other intellectual property assets for biopharmaceutical companies in all stages – from nascent start-ups to multi-billion dollar international conglomerates.
Dr. Hoover held positions including Associate General Counsel, Intellectual Property; Executive Director of Technology Assessment and Licensing; and Executive Director of Scientific Assessment. Prior to that, Dr. Niyikiza joined the pharmaceutical industry in January 1991 with Syntex Corporation (since acquired by Roche Holding AG), in Palo Alto, California, working on the discovery and development of the pain medication, ALEVE®.
Hoover is a partner in the law firm of Nixon & Vanderhye, P.C., based in Arlington, Virginia. His contributions to the field have earned him numerous accolades, such as the Health Care Innovator Award from the Philadelphia Business Journal in 2016, Scientist of the Year by the Wall Street Journal and an Innovation Award for a "New Class of Drugs for Cancer" from Greater Philadelphia.
In his personal life, Dr.
Niyikiza enjoys building homes for his family, reading and traveling. He currently serves as the founder and executive chairman of LEAF4Life Inc., a position he has held since 2018. With over 20 years of experience representing pharmaceutical and biotechnology companies, Dr. Hoover provides L.E.A.F.
GULPH MILLS, PA, August 27, 2024 /24-7PressRelease/ -- Clet Niyikiza, PhD, has been selected for inclusion in Marquis Who's Who.
As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. His earlier career includes significant contributions as a Lilly research fellow and global oncology pharmacogenomics leader at Eli Lilly and Company from 1993 to 2005 after beginning his professional journey as a scientist at Syntex Corporation from 1991 to 1993.
Dr.
Niyikiza's academic background is equally impressive. Newland is the Director of Corporate Security for Arcos Dorados (McDonald’s Latin America). He developed, over those years, a strong international network of investigators and regulatory authority policy makers that resulted in effective development and efficient registration of 10 New Drug Application indications on many of Lilly medicines, including EVISTA® and the two popular anticancer drugs GEMZAR® and ALIMTA®.
Former adjunct professor at two law schools.
Brian Stuglik
Founder of Proventus Health Solutions. Research Fellow at Eli Lilly and Company. Author of nationally published books on the intersections of business and law, and the Supreme Court. Mike then was promoted to a Global Pediatric Medical Director in the Pfizer Pediatric Center of Excellence in both Pfizer’s Chief Medical Office from 2015 – 2018 and then served in Pfizer’s Global Product Development (GPD)/Clinical Trials organization in 2019.
Clet Niyikiza
Dr.
Kenley was an integral member of HGSI’s cross-departmental teams responsible for characterizing the company’s lead targets and he contributed to the preclinical and clinical development of over 30 therapeutics including the approved drugs raxibacumab and BENLYSTA™ (belimumab).
Dr. Additionally, he has developed groundbreaking drugs that have become integral to cancer treatment worldwide, significantly advancing cancer care.
Dr.
Niyikiza is an active member of several industry-related organizations, including the American Association for Cancer Research, the American Society of Clinical Oncology and the C-Change National Forum. He is a member of the American Association for Cancer Research and the American Society of Clinical Oncology. received the 2016 Health Care Innovator Award in recognition of the company's leadership and innovation in the fight against cancer.